Related Experiment Video
Updated: May 2, 2026

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries
Published on: January 22, 2019
Mechanism of IRSp53 inhibition and combinatorial activation by Cdc42 and downstream effectors
David J Kast1, Changsong Yang2, Andrea Disanza3
1Department of Physiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Abstract:
The Rho family GTPase effector IRSp53 has essential roles in filopodia formation and neuronal development, but its regulatory mechanism is poorly understood. IRSp53 contains a membrane-binding BAR domain followed by an unconventional CRIB motif that overlaps with a proline-rich region (CRIB-PR) and an SH3 domain that recruits actin cytoskeleton effectors. Using a fluorescence reporter assay, we show that human IRSp53 adopts a closed inactive conformation that opens synergistically with the binding of human Cdc42 to the CRIB-PR and effector proteins, such as the tumor-promoting factor Eps8, to the SH3 domain. The crystal structure of Cdc42 bound to the CRIB-PR reveals a new mode of effector binding to Rho family GTPases. Structure-inspired mutations disrupt autoinhibition and Cdc42 binding in vitro and decouple Cdc42- and IRSp53-dependent filopodia formation in cells. The data support a combinatorial mechanism of IRSp53 activation.
Insights
The Rho GTPase effector IRSp53 regulates filopodia formation. Its activation requires synergistic binding of Cdc42 and effector proteins, revealing a novel regulatory mechanism.
Area of Science:
- Molecular Biology
- Cell Biology
- Biochemistry
Background:
- IRSp53 is a Rho family GTPase effector crucial for filopodia formation and neuronal development.
- Its precise regulatory mechanism remains largely unelucidated.
- IRSp53 possesses a BAR domain, an unconventional CRIB motif (CRIB-PR), and an SH3 domain.
Purpose of the Study:
- To elucidate the regulatory mechanism of IRSp53.
- To investigate the synergistic activation of IRSp53 by Cdc42 and effector proteins.
- To determine the structural basis of IRSp53-Cdc42 interaction.
Main Methods:
- Fluorescence reporter assay to study IRSp53 conformation.
- Co-expression of IRSp53, Cdc42, and Eps8 in human cells.
- X-ray crystallography to determine the structure of Cdc42 bound to CRIB-PR.
- Site-directed mutagenesis to assess the functional impact of mutations.
Main Results:
- Human IRSp53 exists in a closed, inactive conformation.
- IRSp53 activation occurs synergistically upon binding of human Cdc42 to CRIB-PR and effector proteins (e.g., Eps8) to the SH3 domain.
- Crystal structure reveals a novel binding mode between Cdc42 and the CRIB-PR.
- Mutations disrupting autoinhibition and Cdc42 binding impair filopodia formation in cells.
Conclusions:
- IRSp53 activation follows a combinatorial mechanism.
- Synergistic binding of Cdc42 and effectors is essential for IRSp53 function.
- The findings provide new insights into Rho GTPase effector regulation and filopodia dynamics.
Related Concept Videos
Negative Regulator Molecules
Inhibition of Cdk Activity
Inhibition of CDK Activity
The JAK-STAT Signaling Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Regulation of the Unfolded Protein Response

